Ardent Health Partners (NYSE:ARDT) Given Neutral Rating at JPMorgan Chase & Co.

JPMorgan Chase & Co. restated their neutral rating on shares of Ardent Health Partners (NYSE:ARDT) in a research note published on Tuesday morning, Marketbeat.com reports. The brokerage currently has a $20.00 target price on the stock.

Several other brokerages also recently commented on ARDT. Bank of America downgraded shares of Ardent Health Partners from a “buy” rating to a “neutral” rating and lowered their target price for the company from $22.00 to $19.00 in a report on Wednesday, November 6th. KeyCorp initiated coverage on shares of Ardent Health Partners in a research report on Friday, October 11th. They set an “overweight” rating and a $24.00 target price on the stock. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $23.00 target price on shares of Ardent Health Partners in a report on Thursday, November 14th. Leerink Partners lifted their price target on Ardent Health Partners from $23.00 to $25.00 and gave the stock an “outperform” rating in a report on Tuesday, November 12th. Finally, Stephens restated an “overweight” rating and issued a $24.00 price objective on shares of Ardent Health Partners in a research note on Thursday, September 19th. Two analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $22.00.

Ardent Health Partners Trading Up 0.8 %

Shares of Ardent Health Partners stock opened at $16.76 on Tuesday. The stock’s fifty day moving average is $17.39. Ardent Health Partners has a 12-month low of $14.57 and a 12-month high of $20.72. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78.

Institutional Investors Weigh In On Ardent Health Partners

Large investors have recently added to or reduced their stakes in the company. Franklin Resources Inc. purchased a new stake in Ardent Health Partners during the third quarter valued at about $15,839,000. Barclays PLC bought a new stake in shares of Ardent Health Partners in the third quarter valued at approximately $385,000. Geode Capital Management LLC purchased a new stake in shares of Ardent Health Partners during the 3rd quarter valued at approximately $2,581,000. Pier Capital LLC bought a new position in Ardent Health Partners in the 3rd quarter worth approximately $4,040,000. Finally, Jane Street Group LLC purchased a new position in Ardent Health Partners in the 3rd quarter valued at approximately $567,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.